Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Aptevo Therapeutics Inc fell by 5.73m. Cash Flow from Financing totalled 6.00m or -- of revenues. In addition the company used 11.73m for operations while cash from investing was breakeven.
Cash flow per share | -19.89 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.09 |
---|---|
Tangible book value per share | 1.09 |
More ▼
Balance sheet in USDView more
Current ratio | 1.77 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼